Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

被引:51
|
作者
Esquirol, Albert [1 ]
Pascual, Maria Jesus [2 ]
Kwon, Mi [3 ]
Perez, Ariadna [4 ]
Parody, Rocio [5 ]
Ferra, Christelle [6 ]
Garcia Cadenas, Irene [1 ]
Herruzo, Beatriz [2 ]
Dorado, Nieves [3 ]
Hernani, Rafael [4 ]
Sanchez-Ortega, Isabel [5 ]
Torrent, Anna [6 ]
Sierra, Jorge [1 ]
Martino, Rodrigo [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, IIB St Pau & Jose Carreras Leukemia Res Inst, Hematol Dept, Barcelona, Spain
[2] Hosp Reg Univ, Hematol Dept, Malaga, Spain
[3] Hosp Gregorio Maranon, Hematol Dept, Madrid, Spain
[4] Hosp Clin Univ, Hematol Dept, Madrid, Spain
[5] Bellvitge Hosp, Hematol Dept, Barcelona, Spain
[6] Hosp Badalona Germans Trias & Pujol, Hematol Dept, Badalona, Spain
关键词
BONE-MARROW-TRANSPLANTATION; HIGH-DOSE CYCLOPHOSPHAMIDE; RISK-FACTORS; HEMATOLOGIC MALIGNANCIES; HEMORRHAGIC CYSTITIS; ACUTE-LEUKEMIA; BACTEREMIA; OUTCOMES; DONORS; ADULTS;
D O I
10.1038/s41409-021-01328-4
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Severe infections and their attributable mortality are major complications in recipients of allogeneic hematopoietic stem cell transplantation (alloSCT). We herein report 236 adult patients who received haploSCT with PTCy. The median follow-up for survivors was 37 months. The overall incidence of bloodstream infections by gram-positive and gram-negative bacteria at 37 months was 51% and 46%, respectively. The incidence of cytomegalovirus infection was 69%, while Epstein Barr virus infections occurred in 10% of patients and hemorrhagic cystitis in 35% of cases. Invasive fungal infections occurred in 11% at 17 months. The 3-year incidence of infection-related mortality was 19%. The median interval from transplant to IRM was 3 months (range 1-30), 53% of IRM occurred >100 days post-haploSCT. Risk factors for IRM included age >50 years, lymphoid malignancy, and developing grade III-IV acute GvHD. Bacterial infections were the most common causes of IRM (51%), mainly due to gram-negative bacilli BSI. In conclusion, severe infections are the most common causes of NRM after haploSCT with PTCy, with a reemergence of gram-negative bacilli as the most lethal pathogens. More studies focusing on the severe infections after haploSCT with PTCy and differences with other types of alloSCT in adults are clearly warranted.
引用
收藏
页码:2432 / 2444
页数:13
相关论文
共 50 条
  • [31] Autoimmune Limbic Encephalitis in Patients with Hematologic Malignancies after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Heo, Bu Yeon
    Lee, Myung-Won
    Choi, Suyoung
    Jung, Yunju
    Pham, Thi Thuy Duong
    Jang, Yunseon
    Park, Jung-Hyun
    Kang, Sora
    Koh, Jeong Suk
    Jo, Deog-Yeon
    Kwon, Jaeyul
    Song, Ik-Chan
    CELLS, 2023, 12 (16)
  • [32] Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report
    Parta, Mark
    Hilligoss, Dianne
    Kelly, Corin
    Kwatemaa, Nana
    Theobald, Narda
    Malech, Harry
    Kang, Elizabeth M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (07) : 675 - 680
  • [33] Haploidentical Transplantation Using Double Source of Hematopoietic Stem Cells and Post-Transplant Cyclophosphamide for Acute Leukemias
    Rojas Fonseca-Hial, Ana Marcela
    Parisio, Katya
    Rodrigues de Oliveira, Jose Salvador
    BLOOD, 2019, 134
  • [34] Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report
    Mark Parta
    Dianne Hilligoss
    Corin Kelly
    Nana Kwatemaa
    Narda Theobald
    Harry Malech
    Elizabeth M. Kang
    Journal of Clinical Immunology, 2015, 35 : 675 - 680
  • [35] Comparison of Nonrelapse Mortality After Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation in Hematologic Disease
    Harada, Kaito
    Kanda, Junya
    Hirayama, Masahiro
    Wada, Fumiya
    Uchida, Naoyuki
    Tanaka, Masatsugu
    Nakamae, Hirohisa
    Tokunaga, Masahito
    Ishiwata, Kazuya
    Onizuka, Makoto
    Hasegawa, Yuta
    Fukuda, Takahiro
    Eto, Tetsuya
    Kurita, Naoki
    Kawakita, Toshiro
    Jinguji, Atsushi
    Ishimaru, Fumihiko
    Atsuta, Yoshiko
    Nakasone, Hideki
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (02): : 103e1 - 103e13
  • [36] Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide in Pediatric Hemophagocytic Lymphohistiocytosis
    Diego Medina-Valencia
    Daniela Cleves
    Estefania Beltran
    Natalia Builes
    Alexis A. Franco
    Andrés Felipe Escobar-González
    Manuela Olaya
    Journal of Clinical Immunology, 2021, 41 : 1172 - 1177
  • [37] Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide in Pediatric Hemophagocytic Lymphohistiocytosis
    Medina-Valencia, Diego
    Cleves, Daniela
    Beltran, Estefania
    Builes, Natalia
    Franco, Alexis A.
    Felipe Escobar-Gonzalez, Andres
    Olaya, Manuela
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (06) : 1172 - 1177
  • [38] Successful Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in a Severe Combined Immune Deficiency Patient: a First Report
    Ouederni, Monia
    Mellouli, Fethi
    Ben Khaled, Monia
    Kaabi, Houda
    Picard, Capucine
    Bejaoui, Mohamed
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (05) : 437 - 440
  • [39] Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
    Arcuri, Leonardo Javier
    Mesquita Aguiar, Marina Tayla
    Feitosa Ribeiro, Andreza Alice
    Fonseca Pacheco, Antonio Guilherme
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (12) : 2422 - 2430
  • [40] Successful Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in a Severe Combined Immune Deficiency Patient: a First Report
    Monia Ouederni
    Fethi Mellouli
    Monia Ben Khaled
    Houda Kaabi
    Capucine Picard
    Mohamed Bejaoui
    Journal of Clinical Immunology, 2016, 36 : 437 - 440